Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 19/20 | 0.75 |
| ▸ | CDK9 | P50750 | 18/20 | 0.75 |
| ▸ | CCNT1 | O60563 | 15/20 | 0.75 |
| ▸ | CCNA2 | P20248 | 15/20 | 0.75 |
| ▸ | CDK1 | P06493 | 8/20 | 0.70 |
| ▸ | CDK7 | P50613 | 8/20 | 0.70 |
| ▸ | CCNB1 | P14635 | 6/20 | 0.70 |
| ▸ | CCNH | P51946 | 6/20 | 0.70 |
| ▸ | CCNA1 | P78396 | 4/20 | 0.70 |
| ▸ | GSK3B | P49841 | 1/20 | 0.63 |
| ▸ | CDK4 | P11802 | 4/20 | 0.60 |
| ▸ | AURKA | O14965 | 3/20 | 0.59 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.59 |
| ▸ | WEE1 | P30291 | 2/20 | 0.59 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.59 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.58 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.58 |
| ▸ | JAK2 | O60674 | 1/20 | 0.58 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.58 |
| ▸ | PAK4 | O96013 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5596571 | 0.90 | GSK3B (0.75) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL27664830 | 0.88 | CDK2 (0.77) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL27664777 | 0.87 | CDK2 (0.72) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL4158723 | 0.85 | CDK9 (1.00) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL5161475 | 0.85 | GSK3B (0.72) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL4158701 | 0.85 | CDK2 (0.93) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL27664773 | 0.83 | CDK2 (0.78) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL5159297 | 0.82 | CDK2 (0.75) | CDK2CDK9CCNT1CCNA2CDK1 | |
| SCHEMBL6209137 | 0.81 | CDK2 (0.74) | CDK2CDK9CCNT1CDK1CDK7 | |
| SCHEMBL5161995 | 0.79 | GSK3B (0.69) | CDK2CDK9CCNT1CCNA2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756098-A2 | 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | Cyclacel Limited (GB) | 2007-02-28 | — | — | EP | claimed |
| WO-2005116025-A2 | 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CYCLACEL LIMITED (GB) | 2005-12-08 | — | — | WO | claimed |
| EP-1756098-A2 | 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | Cyclacel Limited (GB) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005116025-A2 | 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CYCLACEL LIMITED (GB) | 2005-12-08 | — | — | WO | disclosed |